Navigating the Future: Self-Administered Parenteral Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

Self-Administered Parenteral Market Size Growth Forecast: What to Expect by 2025?
In recent times, the size of the self-administered parenteral market has experienced significant growth. The market, which is projected to be valued at $24.57 billion in 2024, is expected to increase to $26.04 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%. The upswing during the historic period is a result of multiple factors including the increment in chronic illnesses, an aging demographic, governmental programs, patient enlightenment and support initiatives, and a surge in cases of bone ailments.

How Will the Self-Administered Parenteral Market Size Evolve and Grow by 2029?
The market size for self-administered parenteral is projected to experience consistent expansion in the upcoming years. It is estimated to increase to $31.18 billion by 2029 with a compound annual growth rate (CAGR) of 4.6%. The acceleration during the predicted period can be credited to an increase in patient inclination towards home healthcare, advancements in telemedicine and remote patient monitoring, efforts towards patient education and support, and the rise of personalized medicine. Key trends predicted to occur within this period encompass the inclusion of digital health solutions, personalized drug delivery systems, the advent of targeted therapies, and advancements in biologics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/self-administered-parenteral-global-market-report

What Drivers Are Propelling the Growth of Self-Administered Parenteral Market Forward?
The rise in chronic diseases is predicted to fuel the expansion of the self-administered parenteral market. These diseases, which usually develop over a long period and often demand regular treatment and management, make use of self-administered parenteral products. This allows patients to manage their treatment on their own, significantly improving adherence than with oral medication. For example, the US government agency, National Institutes of Health, noted in January 2023 that the number of people aged 50 and above, suffering from at least one chronic disease, is projected to surge up to 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Hence, the increasing occurrence of chronic diseases is steering the upward progress of the self-administered parenteral market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13927&type=smp

Which Emerging Trends Are Transforming the Self-Administered Parenteral Market in 2025?
Key players in the self-administered parenteral industry are striving to create innovative products like the UDENYCA autoinjector, with the goal of enhancing patient alternatives and control, thereby improving access to treatment. An autoinjector is a medical apparatus engineered to dispense a particular drug in a single dose. It features an intuitive design and immediate, reliable activation upon skin contact. In May 2023, a US biotech firm, Coherus BioSciences Inc., introduced the UDENYCA autoinjector, a self-administered parenteral medication in the US. The UDENYCA Autoinjector is a single-use, pre-filled device that gives patients an alternate way to administer pegfilgrastim. Its design simplifies usage and ensures a full dose of pegfilgrastim via touch-activated skin deployment. Apart from this, it offers a range of user-friendly features that support effective delivery like quick dosing, intuitive design, dual coverage, at-home and in-office use, and a reduction in the risk of febrile neutropenia.

What Are the Key Segments in the Self-Administered Parenteral Market?
The self-administered parenteral market covered in this report is segmented -

1) By Product: Pre-Filled Syringes, Autoinjectors, Pen Injectors, Other Products
2) By Usage: Disposable, Reusable
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Home Healthcare Providers, Specialty Clinics, Other Distribution Channels
4) By Application: Cardiovascular Diseases, Diabetes, Osteoporosis, Pain Management, Hormone Replacement, Other Applications

Subsegments:
1) By Pre-Filled Syringes: Glass Pre-Filled Syringes, Plastic Pre-Filled Syringes
2) By Autoinjectors: Disposable Autoinjectors, Reusable Autoinjectors
3) By Pen Injectors: Insulin Pen Injectors, Growth Hormone Pen Injectors, Other Pen Injectors
4) By Other Products: Infusion Pumps, Needle-Free Injectors, Combination Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13927&type=smp

Who Are the Key Players Shaping the Self-Administered Parenteral Market's Competitive Landscape?
Major companies operating in the self-administered parenteral market report are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Roche Holding AG, Eli Lilly and Company, Novo Nordisk A/S, Becton, inson and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Terumo Corporation, Catalent Inc., Dexcom Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Biocon Limited, Insulet Corporation, Halozyme Therapeutics Inc., Ypsomed AG, Antares Pharma Inc., SHL Medical AG, Owen Mumford Ltd., Novartis AG, Kaleo Inc., Haselmeier AG, Bespak (A Consort Medical Company), Senseonics Holdings Inc., ScPharmaceuticals Inc., Fresenius Kabi AG

What Geographic Markets Are Powering Growth in the Self-Administered Parenteral Market?
North America was the largest region in the self-administered parenteral market in 2024. The regions covered in the self-administered parenteral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13927

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.